IP Street can assist you with questions regarding patent anayltics, patant intelligense, intellecutal proporty and the patant application. Our tools will assist you in writing patant cliams, exploring patant infrengment and understanding patant scoop. Interested in freedom 2 operate and patant valididy? IP Street will help you understand patent duration and all things intellectual property.

IPstreet.com will help you with you understand patents better and provide you with the tools to take your patent searching to a new level.

"A new approach to customer intimacy is critical in the new economic environment and this necessitates a stronger commitment than ever before. Organizations that are best at extracting previously undiscovered insights from vast amounts of customer information have a huge advantage in deepening existing connections and creating new relationships. (1) Make customers part of your team. (2) Solicit customer wants. (3) Co-innovate and interact with customers in new ways. (4) Deliver true process transparency. (5) Tap the value of limitless data. (6) Translate data into insight into action that creates business results. (7) Share information freely to build trust and improve customer relationships." According to IBM 2010, Capitalizing on Complexity: Insights from the Global CEO Study. Patent attorneys and IP counselors are key stakeholders in the innovation economy. We want to empower you with our patent-analytic tools that enables you to have more meaningful (and more profitable) relationships with your clientele. IP Street was founded and is currently directed by Lewis Lee, a well-known and respected attorney in the IP space. He understands the challenging of operating a law firm in the economically-distressed digital age. Not only has he helped ideate ways you can directly use our patent search tools to do things smarter, quicker but he has also directed IP Street to help patent lawyers connect to potential customers.

"At present, it is known that intangible resources, or intellectual capital, are the drivers of economic growth. IPStreet.com's tools can help you understand if your idea is patentable, how to patent an idea, how to conduct a patent search to it's full potential and understand the analytics behind the patent search. We can help with understanding patent duration, patent value and connecting you with an experienced patent lawyer. One of its components is the human resources. Human resources are the main source of knowledge of firms, and it is considered a critical resource, maybe the most important one (Johanson, 2005; Marr and Roos, 2005). For this reason, its management and its development are crucial to increase the value of the firm. The objective of this paper is to analyse the influence that the training expenses have over the total value of the intangibles. From the business management, the expenditure on training are an investment." (Lidia García-Zambrano et al). Let IPstreet.com help you with your HR Director needs.

Myopia is generally what happens when unprecedented opportunities are placed before them. Those in the know generally do better than those in the worry. Consider Cetus, a startup biotech with a focus on a liver drug. The FDA delayed the approval of the drug, and a major funding crisis ensued. Chiron offered to take over the liabilities contingent on the sale of two patents (# 4,683,202 and # 4,683,195) to a third party, Roche Molecule for $300M (in 1993). This sale was stalled because DuPont challenged the validity of the patents, based on the formal claims written by the inventor (not a patent attorney), Kary Mullis. In the end, the soap opera turned out well for the investors with weak constitutions. For $300M, they sold the two patents to Roche, turned the company over to Chiron, and walked away. Kary Mullis won the Nobel prize for his invention embedded in these two patents, known as polymerase chain reaction (PCR) which allows DNA to be cloned. Over 4000 patents in biotech cite these original two patents. In our estimation, $300M represents "pennies on the dollar" valuation of these patents. The shareholders got a payday, and left the game. Roche on the other hand is thriving based on its intangible assets. Let IPstreet.com assist you.